The first patient with Sickle Cell Disease (SCD) has received a transplant of CordIn from Israeli biotech Gamida Cell. CordIn is an alternative for patients awaiting a suitable match for bone marrow transplants. Trials of CordIn are planned for patients with aplastic anemia.
Treatment for Sickle Cell Disease
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.